Silence Therapeutics plc
SLN
$7.35
$0.456.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -88.61M | -64.54M | -79.13M | -71.53M | -45.31M |
| Total Depreciation and Amortization | 555.00K | 582.00K | 577.00K | 579.00K | 593.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.63M | 7.17M | 19.01M | 12.35M | 10.10M |
| Change in Net Operating Assets | 10.16M | -15.68M | -27.64M | -12.21M | -33.02M |
| Cash from Operations | -62.27M | -72.47M | -87.18M | -70.81M | -67.64M |
| Capital Expenditure | -55.00K | -117.00K | -178.00K | -215.00K | -211.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -47.94M | 71.59M | -17.78M | -16.22M | -21.76M |
| Cash from Investing | -47.99M | 71.47M | -17.96M | -16.44M | -21.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15.00K | 15.00K | 7.99M | 9.18M | 142.19M |
| Repurchase of Common Stock | -- | -98.00K | -98.00K | -98.00K | -98.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.00K | -83.00K | 7.89M | 9.08M | 142.09M |
| Foreign Exchange rate Adjustments | 195.00K | 165.00K | 539.00K | 327.00K | 60.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -110.05M | -912.00K | -96.71M | -77.84M | 52.54M |